clinical trials

News

Agios shares slump on sickle cell disease data

Shares in Agios lost nearly half their value after it posted mixed clinical results from a phase 3 trial of its sickle cell disease therapy mitapivat.

R&D

a scientist in the lab holds a white mouse model in their gloved hands

Beyond animal testing: How human data trials are reshaping d...

Researchers are beginning to imagine a future in which development pipelines are more predictive, more efficient, and ultimately more humane.

R&D

black lady smiling and looking at laptop

Working together to innovate on pragmatic clinical trials, w...

In today’s episode, host Jonah Comstock speaks with Rob DiCicco, vice president of portfolio management at TransCelerate Biopharma.

News

Roche extols 'unprecedented' result with breast cancer drug

Roche's oral SERD giredestrant has achieved what the company says is a stellar result as adjuvant treatment for early breast cancer.

News

BMS, J&J give up on milvexian for acute coronary syndrome

BMS and J&J call time on oral anticoagulant milvexian in acute coronary syndrome, but are still running trials in atrial fibrillation and stroke.

News

Novartis says novel drug could counter malaria resistance

Novartis has reported what looks like another big step forward in the treatment of malaria, as a drug with a novel mechanism hits the mark in phase 3.

Agios shares slump on sickle cell disease data

Beyond animal testing: How human data trials are reshaping d...

Working together to innovate on pragmatic clinical trials, w...

Roche extols 'unprecedented' result with breast cancer drug

BMS, J&J give up on milvexian for acute coronary syndrome

Novartis says novel drug could counter malaria resistance

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

clinical trials

Editor's Picks